Compare PRDO & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRDO | VCEL |
|---|---|---|
| Founded | 1994 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.0B |
| IPO Year | N/A | 1997 |
| Metric | PRDO | VCEL |
|---|---|---|
| Price | $28.18 | $38.32 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $42.00 | ★ $60.40 |
| AVG Volume (30 Days) | ★ 841.9K | 583.5K |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | ★ 2.13% | N/A |
| EPS Growth | 17.26 | ★ 236.54 |
| EPS | ★ 2.33 | 0.25 |
| Revenue | ★ $810,888,000.00 | $258,716,999.00 |
| Revenue This Year | $26.43 | $17.86 |
| Revenue Next Year | $3.65 | $18.55 |
| P/E Ratio | ★ $12.11 | $154.78 |
| Revenue Growth | ★ 24.23 | 14.05 |
| 52 Week Low | $23.87 | $29.24 |
| 52 Week High | $38.03 | $63.00 |
| Indicator | PRDO | VCEL |
|---|---|---|
| Relative Strength Index (RSI) | 34.23 | 51.75 |
| Support Level | $27.56 | $35.85 |
| Resistance Level | $28.59 | $42.68 |
| Average True Range (ATR) | 0.90 | 1.81 |
| MACD | 0.17 | -0.38 |
| Stochastic Oscillator | 45.21 | 36.78 |
Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segments include the American InterContinental University, the University of St. Augustine for Health Sciences, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services, with the majority of the students enrolled in programs offered fully online. The majority of the company's revenue comes from the Colorado Technical University segment.
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.